Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bifidum BAG
- Development stage
- Unknown
- Lead developer
- Vector-BiAlgam
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Bifidum BAG is a liquid probiotic concentrate developed by AO Vector-BiAlgam, containing a high titer of live, active bifidobacteria. The formulation consists of a complex of strains including *Bifidobacterium bifidum* and *Bifidobacterium longum*. It is designed to restore and maintain healthy intestinal microflora by colonizing the gastrointestinal tract and producing essential organic acids, B-group vitamins, and natural antimicrobial substances. Bifidum BAG is primarily indicated for the treatment and prevention of intestinal dysbiosis, gastrointestinal infections, and as supportive therapy during and after antibiotic treatment. It is often used as a core component of a comprehensive probiotic regimen alongside other products like Ecoflor and Trilact.
- Brand names
- Bifidum BAG
- Other names
- Бифидум БАГBifidobacterium bifidum + Bifidobacterium longum concentrate
Beyond the preview
Go deeper on Bifidum BAG.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bifidum BAG.